acamprosate vs ropinirole
PlainMeds reviewed this comparison against our methodology in August 2026. It places FDA and CMS record fields side by side, without recommending either medication.
Side-by-side comparison of acamprosate and ropinirole. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Campral
Requip
Acamprosate is a medicine that can help you stay away from alcohol if you are alcohol-dependent and have already stopped drinking. It should be used with counseling and support.
Ropinirole is a medicine that acts like dopamine in your brain. It is used to treat Parkinson's disease and restless legs syndrome.
Acamprosate helps people who are alcohol-dependent to not drink alcohol. You must have already stopped drinking before you start taking acamprosate. This medicine works best when it is part of a complete treatment plan that includes counseling and support.
Ropinirole is used to treat Parkinson's disease. It can also help with moderate-to-severe primary Restless Legs Syndrome (RLS). RLS causes an uncomfortable feeling in the legs and a strong urge to move them, usually at night.
Acamprosate is similar to a natural substance in your brain. It is thought to work by helping to restore the normal balance of brain activity that is changed by long-term alcohol use. This can reduce your craving for alcohol.
Ropinirole works by mimicking the effects of dopamine, a natural chemical in the brain. Dopamine helps control movement and coordination. By acting like dopamine, ropinirole can help reduce the symptoms of Parkinson's disease and RLS.
- • Accidental injury
- • Weakness
- • Pain
- • Loss of appetite
- • Diarrhea
- • Nausea
- • Sleepiness
- • Dizziness
- • Fainting
- • Feeling weak or tired
- Hypotension 14
- Asthenia 13
- Condition Aggravated 13
- Acute Kidney Injury 12
- Coma 12
- Fall 1,004
- Fatigue 920
- Nausea 852
- Dizziness 721
- Hallucination 711
Acamprosate may increase the risk of suicidal thoughts or actions. Your doctor should watch you for depression or suicidal thoughts. Tell your doctor right away if you have any new or worsening symptoms of depression or suicidal thoughts.
Ropinirole can cause you to fall asleep suddenly, even during normal daily activities. Some people have fainted while taking ropinirole. Ropinirole can lower your blood pressure, especially when you stand up. It may also cause hallucinations or unusual behaviors. Some people taking ropinirole have reported problems with impulse control, such as gambling or overeating.
Acamprosate may harm your unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. It is not known if acamprosate passes into breast milk. Talk to your doctor if you are breastfeeding.
Ropinirole may harm your unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. It is not known if ropinirole passes into breast milk, but it may reduce milk production.
Also Compare, Nearby Drugs
Compare ropinirole with
How to Read This acamprosate vs ropinirole Comparison
acamprosate is classified in the GABA Analog (Alcohol Dependence) drug class, while ropinirole sits within the Dopamine Agonist class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, acamprosate has 64 submissions while ropinirole has 4,208. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for acamprosate or ropinirole.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.